XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
A phase 4 trial registered on ClinicalTrials.gov. The registry status is completed. It enrolled 464 participants.
Also called NCT02122718
- Study
- In this atlas
Overview
- Design
- Interventional study; randomized; quadruple masking; primary purpose treatment
- Phase
- Phase 4
- Enrolled
- 464 participants
- Registry
-
NCT02122718
-
- Start date
- (registry gives no type)
- Primary completion
- (actual)
- Completion
- (actual)
- Countries
- United Kingdom
- Registry status
- Completed
Technical summary
Registry record NCT02122718. Randomized; quadruple masking; primary purpose treatment. Start 2014-05 (registry gives no type); primary completion 2021-02 (actual). Results not posted.
The registry's words
Labels as the registry gives them, not rewritten.
- Brief title
- XILO-FIST, the Effect of Allopurinol on the Brain Heart and Blood Pressure After Stroke
- Acronym
- XILO-FIST
- Condition
- Ischaemic Stroke
- Intervention (Drug)
- Allopurinol
- Intervention (Drug)
- Placebo
- Lead sponsor
- NHS Greater Glasgow and Clyde
- Collaborator
- University of Glasgow
Record details
- Record id
cardio:ct-nct02122718- Content hash
32618e8ad6d6190dea5cfb1f74b129c7d26e4faf878fe416d993b23f990062eb